The 52-Week Low Club
Tweet
Share
E-mailGet Alerts BZH Hot Sheet
Join SI Premium – FREE
From 247WallSt
Beazer Homes (NYSE: BZH) Rival Lennar posts horrible results. Sub-prime and real estate problems keeping taking home builders down. Drops to $30.85 against 52-week high of $69.61.
Technical Olympic (NYSE: TOA) Another home builder. Down to $3.72 from $23.
McClatchy Newspapers (NYSE: MNI) Back on the list again as life gets worse for newspaper stocks. Drops to $31.52 from $50.64.
CarMax (NYSE: KMX) Used car company. Split stock 2.1 ratio. Down to $26.80 from $58.89.
Tecumseh Products (Nasdaq: TECUA) Delays annual report. Brazilian engine builder seeks Chapter 11 equivalent. Down to $8.85 from 52-week high of $25.37.
BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) Stops trials of clinical work on cancer drug. Drops to $7.80 from 52-week high of $21.12.
Hana Biosciences (Nasdaq: HNAB) The Associated Press said that the company "stopping studies of Talvesta due to toxicity problems". Stock down to $1.82 from 52-week high of $12.94.
Angiotech Pharmaceuticals Inc (Nasdaq: ANPI) Company makes a drug used in stents, and the news on stent use in heart patients has been bad the last 48 hours. Down to $5.33 from 52-week high of $15.39.
Douglas A. McIntyre
For more market insight go to http://www.247wallst.com/
Beazer Homes (NYSE: BZH) Rival Lennar posts horrible results. Sub-prime and real estate problems keeping taking home builders down. Drops to $30.85 against 52-week high of $69.61.
Technical Olympic (NYSE: TOA) Another home builder. Down to $3.72 from $23.
McClatchy Newspapers (NYSE: MNI) Back on the list again as life gets worse for newspaper stocks. Drops to $31.52 from $50.64.
CarMax (NYSE: KMX) Used car company. Split stock 2.1 ratio. Down to $26.80 from $58.89.
Tecumseh Products (Nasdaq: TECUA) Delays annual report. Brazilian engine builder seeks Chapter 11 equivalent. Down to $8.85 from 52-week high of $25.37.
BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) Stops trials of clinical work on cancer drug. Drops to $7.80 from 52-week high of $21.12.
Hana Biosciences (Nasdaq: HNAB) The Associated Press said that the company "stopping studies of Talvesta due to toxicity problems". Stock down to $1.82 from 52-week high of $12.94.
Angiotech Pharmaceuticals Inc (Nasdaq: ANPI) Company makes a drug used in stents, and the news on stent use in heart patients has been bad the last 48 hours. Down to $5.33 from 52-week high of $15.39.
Douglas A. McIntyre
For more market insight go to http://www.247wallst.com/
You May Also Be Interested In
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
- Lindsay, Palantir rise premarket; Ouster, Bending Spoons fall
- Domino's stock near 52-week low, down 45% from peak ahead of Q2 earnings
Create E-mail Alert Related Categories
ContributorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
